Home/News/News details

Heparin Sodium Market - Industry Outlook, Size,Share, Growth Prospects, Key Opportunities, Trends and Forecasts, 2017-2021

May 19, 2017

Heparin Sodium Market - Industry Outlook, Size,Share, Growth Prospects, Key Opportunities, Trends and Forecasts, 2017-2021

Heparin Sodium which is also known as unfractionated heparin (UFH) and low molecular weight heparin, heparin sodium is a blood thinner medication. Heparin sodium was discovered in 1916 and is on World Health Organization's List of Essential Medicines. 

Common side effects are pain at the site of injection, bleeding, low blood platelet, heparin induced thrombocytopenia.

Get Discount on this Report @ https://www.qyresearchgroups.com/check-discount/328069

Medical uses of Heparin Sodium

  • Venous Thromboembolism treatment- It is suggested by the American College of Chest Physicians (ACCP) for primary treatment of acute proximal PE or DVT, especially in cases of renal impairment
  • Thromboprophylaxis in General Surgery- ACCP recommends low-dose heparin in patients undergoing general surgery including GI, abdominal, urologic, gynaecological, bariatric, vascular, reconstructive/plastic surgeries
  • Thromboprophylaxis in Cardiac Surgery- ACCP suggests low dose heparin in cardiac surgery patients with complicated postoperative phase.
  • Thromboprophylaxis in Neurosurgery- used in craniotomy, spinal surgery
  • Thromboprophylaxis in Thoracic Surgery
  • Thromboprophylaxis in Major Orthopaedic Surgery- hip fracture surgery, total hip-replacement surgery, total knee-replacement surgery
  • Thromboprophylaxis in particular medical conditions – acute and critically ill patients, malignancies
  • Thromboprophylaxis in Trauma- traumatic brain injury, spinal surgery for trauma, acute spinal cord injury
  • Prevention and treatment of Thromboembolism during pregnancy and complications of pregnancy
  • Prevention and treatment of Venous Thromboembolism in Paediatric Patients-
  • To reduce the risk of stroke and systemic embolism during cardioversion of atrial fibrillation/flutter-
  • Prevention of Thromboembolism related to  Prosthetic mechanical Heart Valves
  • Prevention and treatment Renal Vein Thrombosis in children and neonates
  • Prevention and treatment of Arterial Thromboembolism
  • To reduce the extent of ischemic injury in cases of acute arterial emboli or thrombosis;
  • Treatment of acute and chronic coagulopathies like Disseminated Intravascular Coagulation-
  • Prevention and treatment of Thrombosis Associated with Indwelling Venous or Arterial Devices
  • Used along with antiplatelet medications like aspirin during and after coronary artery reperfusion for prevention of ST-Segment Elevation MI (STEMI)
  • To prevent Acute Ischemic Complications of PCI

Ask for Sample copy @ https://www.qyresearchgroups.com/request-sample/328069

Table of Contents

1 Market Overview
1.1 Heparin Sodium Introduction
1.2 Market Analysis by Type
1.2.1 Type 1
1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Treatment of Venous Thromboembolism
1.3.2 Complications of Pregnancy
1.3.3 Cardioversion of Atrial Fibrillation/Flutter
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shenzhen Hepalink
2.1.1 Business Overview
2.1.2 Heparin Sodium Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shenzhen Hepalink Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Nanjing King-friend
2.2.1 Business Overview
2.2.2 Heparin Sodium Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2

Pre Order Enquiry: https://www.qyresearchgroups.com/send-an-enquiry/328069

2.2.3 Nanjing King-friend Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dongcheng Biochemicals
2.3.1 Business Overview
2.3.2 Heparin Sodium Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Dongcheng Biochemicals Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Changzhou Qianhong Bio-pharma
2.4.1 Business Overview
2.4.2 Heparin Sodium Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pharma Action
2.5.1 Business Overview
2.5.2 Heparin Sodium Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Pharma Action Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Opocrin
2.6.1 Business Overview
2.6.2 Heparin Sodium Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Opocrin Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bioib?rica
2.7.1 Business Overview
2.7.2 Heparin Sodium Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Bioib?rica Heparin Sodium Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Aspen Oss
2.8.1 Business Overview
2.8.2 Heparin Sodium Type and Applications

….

Read More: https://www.qyresearchgroups.com/report/global-heparin-sodium-market-by-manufacturers-countries-type-and-application-forecast-to-2022

About Us:

QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.

Contact us:

Email- sales@qyresearchgroups.com

Web- https://www.qyresearchgroups.com

Follow Us:

LinkedIn | Twitter| Facebook

 

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.